Skip to main content

The Enigma of Activating Isoforms of ITIM-Bearing Molecules

  • Chapter

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 244))

Abstract

A novel family of inhibitory receptors has been described recently Vivier and Daeron 1997) based on the presence of a conserved immunoreceptor tyrosine-based inhibition motif (ITIM) in the intracytoplasmic portion. The first ITIM-bearing receptors were identified, in cells of hematopoietic origin, as the low affinity receptors for immunoglobulins, FcγRIIB, in B cells (Amigorena et al. 1992; Daëron et al. 1995) and the killer cell Ig-like receptors (KIR) for MHC class I molecules in natural killer (NK) cells (Olcese et al. 1996; Burshtyn et al. 1996). Subsequently, other ITIM-bearing molecules have been described in both hematopoietic cells [PIR-B, (Kubagawa et al. 1997), ILT-2 and -3, (Cella et al. 1997; Samaridis and Colonna 1997), LIR molecules (Borges et al. 1997), MIR molecules, (Wagtmann et al. 1997), CD22, (Sato et al. 1998), and CD72, (Wu et al. 1998)] and nonhematopoietic cells [SIRPα, (Kharitonenkov et al. 1997)]. All these molecules are characterized by the presence of one or more ITIM sequences in their intracytoplasmic portions. This motif is responsible for the transduction of inhibitory signals inside the cells. The ITIM-bearing receptors belong to two families: the immunoglobulin superfamily (IgSF) and the lectin-like superfamily (LSF).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Amigorena S, Bonnerot C, Drake JR, Choquet D, Hunziker W, Guillet JG, Webster P, Sautes C, Mellman I, Fridman WH (1992) Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808–1812

    Article  PubMed  CAS  Google Scholar 

  • Biassoni R, Cantoni C, Falco M, Verdiani S, Bottino C, Vitale M, Conte R, Poggi A, Moretta A, Moretta L (1996) The human leukocyte antigen (HLA)-C-specific “activatory” or “inhibitory” natural killer cell receptors display highly homologous extracellular domains, but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183:645–650

    Article  PubMed  CAS  Google Scholar 

  • Biassoni R, Pessino A, Malaspina A, Cantoni C, Bottino C, Sivori S, Moretta L, Moretta A (1997) Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 27:3095–3099

    Article  PubMed  CAS  Google Scholar 

  • Borges L, Hsu ML, Fanger N, Kubin M, Cosman D (1997) A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159:5192–5196

    PubMed  CAS  Google Scholar 

  • Bottino C, Sivori S, Vitale M, Cantoni C, Falco M, Pende D, Morelli L, Augugliaro R, Semenzato G, Biassoni R, Moretta L, Moretta A (1996) A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 26:1816–1824

    Article  PubMed  CAS  Google Scholar 

  • Braud VM, Allan DS, O’Callaghan CA, Soderstrom K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2 A, B, and C. Nature 391:795–799

    Article  PubMed  CAS  Google Scholar 

  • Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagoplan S, Berrada K, Yi T, Kinet J-P, Long EO (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77–85

    Article  PubMed  CAS  Google Scholar 

  • Cantoni C, Biassoni R, Pende D, Sivori S, Accame L, Pareti L, Semenzato G, Moretta L, Moretta A, Bottino C (1998) The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol 28:327–338

    Article  PubMed  CAS  Google Scholar 

  • Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M (1997) A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 185:1743–1751

    Article  PubMed  CAS  Google Scholar 

  • Colonna M (1998) Unmasking the killer’s accomplice. Nature 391:642–643

    Article  PubMed  CAS  Google Scholar 

  • Daëron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH (1995) The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3:635–646.

    Article  PubMed  Google Scholar 

  • Dohring C, Samaridis J, Colonna M (1996) Alternatively spliced forms of human killer inhibitory receptors. Immunogenetics 44:227–230

    Article  PubMed  CAS  Google Scholar 

  • Glienke J, Sobanov Y, Brostjan C, Steffens C, Nguyen C, Lehrach H, Hofer E, Francis F (1998) The genomic organization of NKG2 C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 48:163–173

    Article  PubMed  CAS  Google Scholar 

  • Karre K, Welsh RM (1997) Viral decoy vetoes killer cell. Nature 386:446–447

    Article  PubMed  CAS  Google Scholar 

  • Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A (1997) A family of proteins that inhibit signaling through tyrosine kinase receptors. Nature 386:181–186

    Article  PubMed  CAS  Google Scholar 

  • Kubagawa H, Burrows PD, Cooper MD (1997) A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Nat Acad Sci USA 94:5261–5266

    Article  PubMed  CAS  Google Scholar 

  • Lanier LL (1998a) NK cell receptors. Annu Rev Immunol 16:359–393

    Article  PubMed  CAS  Google Scholar 

  • Lanier LL, Corliss B, Wu J, Leong C, Phillips JH (1998b) Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703–707

    Article  PubMed  CAS  Google Scholar 

  • Lanier LL, Corliss B, Wu J, Phillips JH (1998c) Association of DAP12 with activating CD94/NKG2 C NK cell receptors. Immunity 8:693–701

    Article  PubMed  CAS  Google Scholar 

  • Lee N, Liano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE (1998) HLA-E is major ligand for the natural killer inhibitory receptor CD94/NKG2 A. Proc Natl Acad Sci USA 95:5199–5204

    Article  PubMed  CAS  Google Scholar 

  • Long EO, Colonna M, Lanier LL (1996) Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunol Today 17:100.

    Article  PubMed  CAS  Google Scholar 

  • Mason LH, Anderson SK, Yokoyama WM, Smith HRC, RW-P, Ortaldo JR (1996) The Ly49D receptor activates murine natural killer cells. J Exp Med 184:2119–2128

    Article  PubMed  CAS  Google Scholar 

  • Mason LH, Willette-Brown J, Anderson SK, Gosselin P, Shores EW, Love PE, Ortaldo JR, McWicar DW (1998) Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly49D signal transduction. J Immunol 160:4148–4151

    PubMed  CAS  Google Scholar 

  • Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L (1995) Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 182:875–884

    Article  PubMed  CAS  Google Scholar 

  • Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L (1996) Receptors for HLA class I molecules in human natural killer cells. Annu Rev Immunol 14:619–648

    Article  PubMed  CAS  Google Scholar 

  • Nakamura MC, Linnemeyer PA, Niemi EC, Mason LH, Ortaldo JR, Ryan JC, Seaman WE (1999) Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med 189:493–500

    Article  PubMed  CAS  Google Scholar 

  • Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E (1997) Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158:5083–5086

    PubMed  CAS  Google Scholar 

  • Olcese L, Lang P, Vély F, Cambiaggi A, Marguet D, Blery M, Hippen KL, Biassoni R, Moretta A, Moretta L, Cambier JC, Vivier E (1996) Human and mouse killer-cell inhibitory receptors recruit PTP1 C and PTP1D protein tyrosine phosphatases. J Immunol 156:4531–4534

    PubMed  CAS  Google Scholar 

  • Renard V, Cambiaggi A, Vély F, Blery M, Olcese L, Olivero S, Bouchet M, Vivier E (1997) Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol Rev 155:205–221

    Article  PubMed  CAS  Google Scholar 

  • Samaridis J, Colonna M (1997) Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 27:660–665

    Article  PubMed  CAS  Google Scholar 

  • Sato S, Tuscano JM, Inaoki M, Tedder TF (1998) CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. Semin Immunol 10:287–297

    Article  PubMed  CAS  Google Scholar 

  • Smith KM, Wu J, Bakker ABH, Phillips JH, Lanier LL (1998) Ly49D and Ly49H associate with mouse DAP 12 and form-activating receptors. J Immunol 161:7–10

    PubMed  CAS  Google Scholar 

  • Takei F, Brennan J, Mager DL (1997) The Ly-49 family: genes proteins and recognition of class I MHC. Immunol Rew 155:67

    Article  CAS  Google Scholar 

  • Tomasello E, Olcese L, Vély F, Geourgeon C, Bléry M, Moqrich A, Gautheret D, Djabali M, Mattei MG, Vivier E (1998) Gene structure, expression pattern and biological activity of mouse KAR-associated protein KARAP/DAP12. J Biol Chem. 273:34115

    Article  PubMed  CAS  Google Scholar 

  • Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse CD94/NKG2 A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b. J Exp Med 188:1841–1848

    Article  PubMed  CAS  Google Scholar 

  • Vély F, Vivier E (1997) Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J Immunol 159:2075–2077

    PubMed  Google Scholar 

  • Vivier E, Daëron M (1997) Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 18:286–291

    Article  PubMed  CAS  Google Scholar 

  • Wagtmann N, Rojo S, Eichler E, Mohrenweiser H, Long EO (1997) A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors. Curr Biol 7:615–618

    Article  PubMed  CAS  Google Scholar 

  • Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N (1998) Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. Curr Biol 8:1009–1017

    Article  Google Scholar 

  • Wu Y, Nadler MJS, Brennan LA, Gish GD, Timms JF, Fusaki N, Jongstra-Bilen J, Tada N, Pawson T, Wither J, Neel BG, Hozumi N (1998) The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. J Immunol 161:571–577

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Cambiaggi, A., Lucas, M., Vivier, E., Vély, F. (1999). The Enigma of Activating Isoforms of ITIM-Bearing Molecules. In: Daëron, M., Vivier, E. (eds) Immunoreceptor Tyrosine-based Inhibition Motifs. Current Topics in Microbiology and Immunology, vol 244. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58537-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58537-1_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63634-9

  • Online ISBN: 978-3-642-58537-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics